|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646754355 |
003 |
OCoLC |
005 |
20231117033212.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
750720s1986 nyua ob 001 0 eng d |
010 |
|
|
|z 52013360
|
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d DEBSZ
|d LEAUB
|d VLY
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1162475398
|
020 |
|
|
|a 0120066467
|q (electronic bk.)
|
020 |
|
|
|a 9780120066469
|q (electronic bk.)
|
020 |
|
|
|a 9786611409128
|
020 |
|
|
|a 6611409122
|
020 |
|
|
|a 0080562280
|
020 |
|
|
|a 9780080562285
|
035 |
|
|
|a (OCoLC)646754355
|z (OCoLC)1162475398
|
050 |
|
4 |
|a RC267
|b .A4546 1986eb
|
082 |
0 |
4 |
|a 616.99/4
|2 23
|
245 |
0 |
0 |
|a Advances in cancer research.
|n Volume 46.
|p Interferon treatment of human neoplasia /
|c edited by Hans Strander.
|
246 |
3 |
0 |
|a Interferon treatment of human neoplasia
|
260 |
|
|
|a New York :
|b Academic Press,
|c 1986.
|
300 |
|
|
|a 1 online resource (265 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Advances in cancer research ;
|v v. 46
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Advances in Cancer Research: Interferon Treatment of Human Neoplasia; Copyright Page; Contents; Preface; Chapter 1. Interferons (IFNs); I. Introduction; II. Types; III. Production and Purification; IV. Induction and Production Control; V. Genetics; Chapter 2. General Action; I. Action on Cells in General; II. Action on the Cell Surface; III. Tumor Viruses and Oncogenes; IV. Biological Response Modifiers; V. IFNs and Prostaglandins; Chapter 3. Anti-Growth Effects; I. The Anti-Growth Concept; II. Anti-Growth Effects in Tissue Culture; III. Colony Techniques
|
505 |
8 |
|
|a IV. Theory behind the Anti-Growth ConceptV. Nude Mouse Experiments; Chapter 4. Effects on the Immune System; I. General Effects; II. IFNs and NK Cells; III. Other Effector Systems; IV. Immunoregulatory Circuits; Chapter 5. Effects on Other Parameters; I. Receptors and Somatic Antigens; II. Tumor Cell Antigens and Other Markers; III. Various Laboratory Parameters; Chapter 6. Pharmacology and Toxicity; I. IFN Effects in Animals-General Implications; II. Animal Toxicity; III. IFN Titrations and Pharmacokinetics; IV. Anti-IFN Antibodies.; V. Side Effects and Toxicity; VI. IFN and Disease
|
505 |
8 |
|
|a Chapter 7. Animal Tumor ModelsText; Chapter 8. Treatment of Human Papillomavirus-Associated Tumors; I. Local Treatment of Human Papillomavirus-Associated Tumors; II. IFN Treatment of Juvenile Laryngeal Papillomatosis; III. Systemic IFN Treatment of Other HPV-Associated Tumors; Chapter 9. Regional Treatment of Other Tumors; I. Intra- and Peritumoral IFN Therapy; II. Local Treatment of Malignant Melanoma; III. Local Treatment of Breast Cancer; IV. Local Treatment of Cancer of the Uterine Cervix; V. Local Treatment of Neurological Tumors; VI. Local Treatment of Head and Neck Tumors
|
505 |
8 |
|
|a VII. Local Treatment of Lung TumorsVIII. Local Treatment of Bladder Tumors; IX. Intraarterial IFN Therapy; Chapter 10. Systemic Therapy of Indignant Disease; I. Systemic IFN Therapy of Tumors-Screening Trials; II. Systemic Treatment of Leukemias; III. Systemic Treatment of Lymphomas; IV. Systemic Treatment of Myelomatosis; V. Systemic Treatment of Kaposi's Sarcoma; VI. Systemic Treatment of Soft Tissue Sarcomas; VII. Systemic Treatment of Osteosarcomas; VIII. Systemic Treatment of Malignant Melanoma; IX. Systemic Treatment of Renal Cell Carcinoma; X. Systemic Treatment of Lung Cancer
|
505 |
8 |
|
|a XI. Systemic Treatment of Gastric CancerXII. Systemic Treatment of Colorectal Carcinoma; XIII. Systemic and Intraarterial IFN Treatment of Liver Cancer; XIV. Systemic Treatment of Carcinoids; XV. Systemic Treatment of Nasopharyngeal Carcinoma; XVI. Systemic Treatment of Brain Tumors; XVII. Systemic Treatment of Neuroblastoma; XVIII. Systemic Treatment of Prostate Carcinoma; XIX. Systemic Treatment of Carcinoma of the Uterine Cervix; XX. Systemic Treatment of Ovarian Carcinoma; XXI. Systemic Treatment of Breast Cancer; Chapter 11. Inducers; Text; Chapter 12. Other Forms of IFN Therapy
|
520 |
|
|
|a ADVANCES IN CANCER RESEARCH, VOLUME 46.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Cancer
|x Research.
|
650 |
|
0 |
|a Oncology, Experimental.
|
650 |
|
2 |
|a Neoplasms, Experimental
|0 (DNLM)D009374
|
650 |
|
6 |
|a Cancer
|x Recherche.
|0 (CaQQLa)201-0004697
|
650 |
|
6 |
|a Canc�erologie exp�erimentale.
|0 (CaQQLa)201-0049886
|
650 |
|
7 |
|a Cancer
|x Research
|2 fast
|0 (OCoLC)fst00845497
|
650 |
|
7 |
|a Oncology, Experimental
|2 fast
|0 (OCoLC)fst01045747
|
700 |
1 |
|
|a Strander, Hans.
|
776 |
0 |
8 |
|i Print version:
|t Advances in cancer research. Volume 46. Interferon treatment of human neoplasia.
|d New York : Academic Press, 1986
|w (DLC) 52013360
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120066469
|z Texto completo
|